Li Meng, Qiu Yong, Guo Mingcheng, Zhang Shu, Wang Gengsheng, Wang Ya, Xia Lan, Gao Qian
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Wusheng County Center for Disease Control and Prevention, Guang'an, 638401, China.
Tuberculosis (Edinb). 2022 Mar;133:102174. doi: 10.1016/j.tube.2022.102174. Epub 2022 Jan 31.
Recurrent tuberculosis (TB) in China has been studied in urban areas but not in rural settings. We conducted a retrospective cohort study on all successfully treated bacteriologically confirmed TB patients between 2009 and 2020 in Wusheng County, Sichuan Province using whole-genome sequencing (WGS). Isolates differing by ≤ 12 single nucleotide polymorphisms (SNPs) were considered relapse, otherwise were considered exogenous reinfection, and molecular drug susceptibility results were also compared. In total, 4.9% (75/1532) of successfully treated cases had subsequent bouts of TB, with 4 patients having two subsequent bouts, yielding a total of 79 events and a rate of 8.56 (95% CI 6.86-10.67) cases per 1000 person years, 8.9 times higher than in the general population. Most recurrences (74.4%, 58/79) occurred within three years. The risk for recurrent TB was increased for men and patients with drug-resistant isolates. Among the 44 recurrent events with genotyped paired isolates, 39 were classified as relapse and 5 as exogenous reinfection. Ten (25%, 10/40) recurrent patients acquired new resistance during treatment. Recurrent TB in rural Wusheng was mostly relapse and associated with drug resistance, suggesting the need to improve patient management, resistance testing and patient follow-up for at least 3 years after completing treatment.
中国对复发性结核病的研究多集中在城市地区,农村地区尚未涉及。我们利用全基因组测序(WGS)技术,对四川省武胜县2009年至2020年间所有成功治愈的经细菌学确诊的结核病患者进行了一项回顾性队列研究。单核苷酸多态性(SNP)差异≤12的菌株被视为复发,否则视为外源性再感染,并对分子药敏结果进行了比较。共有4.9%(75/1532)的成功治疗病例随后再次感染结核病,4例患者出现两次后续发作,共发生79次复发事件,发病率为每1000人年8.56例(95%可信区间6.86 - 10.67),比普通人群高8.9倍。大多数复发(74.4%,58/79)发生在三年内。男性和耐药菌株患者复发性结核病的风险增加。在44例有配对菌株基因分型的复发事件中,39例被归类为复发,5例为外源性再感染。10例(25%,10/40)复发患者在治疗期间获得了新的耐药性。武胜农村地区的复发性结核病大多为复发,且与耐药性有关,这表明需要改善患者管理、耐药性检测,并在完成治疗后至少3年内对患者进行随访。